Haaz MC - Search Results

1

Impact of different fluorouracil biochemical modulators on cellular dihydropyrimidine dehydrogenase.

Haaz MC, Fischel JL, Formento P, Renée N, Etienne MC, Milano G. Haaz MC, et al. Cancer Chemother Pharmacol. 1996;38(1):52-8. doi: 10.1007/s002800050447. Cancer Chemother Pharmacol. 1996. PMID: 8603452

2

Molecular determinants of the cytotoxicity of platinum compounds: the contribution of in silico research.

Vekris A, Meynard D, Haaz MC, Bayssas M, Bonnet J, Robert J. Vekris A, et al. Among authors: haaz mc. Cancer Res. 2004 Jan 1;64(1):356-62. doi: 10.1158/0008-5472.can-03-2258. Cancer Res. 2004. PMID: 14729645

3

Metabolism of irinotecan (CPT-11) by human hepatic microsomes: participation of cytochrome P-450 3A and drug interactions.

Haaz MC, Rivory L, Riché C, Vernillet L, Robert J. Haaz MC, et al. Cancer Res. 1998 Feb 1;58(3):468-72. Cancer Res. 1998. PMID: 9458091

4

Identification of a new metabolite of CPT-11 (irinotecan): pharmacological properties and activation to SN-38.

Dodds HM, Haaz MC, Riou JF, Robert J, Rivory LP. Dodds HM, et al. Among authors: haaz mc. J Pharmacol Exp Ther. 1998 Jul;286(1):578-83. J Pharmacol Exp Ther. 1998. PMID: 9655905

5

Glucuronidation of SN-38, the active metabolite of irinotecan, by human hepatic microsomes.

Haaz MC, Rivory L, Jantet S, Ratanasavanh D, Robert J. Haaz MC, et al. Pharmacol Toxicol. 1997 Feb;80(2):91-6. doi: 10.1111/j.1600-0773.1997.tb00289.x. Pharmacol Toxicol. 1997. PMID: 9060040

6

Determination of drug interactions occurring with the metabolic pathways of irinotecan.

Charasson V, Haaz MC, Robert J. Charasson V, et al. Among authors: haaz mc. Drug Metab Dispos. 2002 Jun;30(6):731-3. doi: 10.1124/dmd.30.6.731. Drug Metab Dispos. 2002. PMID: 12019202

7

The transformation of irinotecan (CPT-11) to its active metabolite SN-38 by human liver microsomes. Differential hydrolysis for the lactone and carboxylate forms.

Haaz MC, Rivory LP, Riché C, Robert J. Haaz MC, et al. Naunyn Schmiedebergs Arch Pharmacol. 1997 Aug;356(2):257-62. doi: 10.1007/pl00005049. Naunyn Schmiedebergs Arch Pharmacol. 1997. PMID: 9272733

8

Biosynthesis of an aminopiperidino metabolite of irinotecan [7-ethyl-10-[4-(1-piperidino)-1-piperidino]carbonyloxycamptothecine] by human hepatic microsomes.

Haaz MC, Riché C, Rivory LP, Robert J. Haaz MC, et al. Drug Metab Dispos. 1998 Aug;26(8):769-74. Drug Metab Dispos. 1998. PMID: 9698291

9

Identification and properties of a major plasma metabolite of irinotecan (CPT-11) isolated from the plasma of patients.

Rivory LP, Riou JF, Haaz MC, Sable S, Vuilhorgne M, Commerçon A, Pond SM, Robert J. Rivory LP, et al. Among authors: haaz mc. Cancer Res. 1996 Aug 15;56(16):3689-94. Cancer Res. 1996. PMID: 8706009

10

Hepatic extraction, metabolism, and biliary excretion of irinotecan in the isolated perfused rat liver.

Farabos C, Haaz MC, Gires P, Robert J. Farabos C, et al. Among authors: haaz mc. J Pharm Sci. 2001 Jun;90(6):722-31. doi: 10.1002/jps.1028. J Pharm Sci. 2001. PMID: 11357175

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

11 results

Search Page

Filters